Submitted by Anonymous (not verified) on 27 March 2024 - 10:41
Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 36, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Arixtra, fondaparinux sodium, Date of authorisation: 20/03/2002, Revision: 36, Status: Authorised